Treace Medical Concepts (TMCI) Total Liabilities (2020 - 2026)
Treace Medical Concepts (TMCI) posted Total Liabilities of $106.9 million for Q1 2026, up 3.55% on a QoQ basis from $103.2 million in Q4 2025, and up 6.37% year-over-year from $100.5 million in Q1 2025.
Treace Medical Concepts (TMCI) Total Liabilities (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Total Liabilities history runs 7 years deep, the most recent figure standing at $106.9 million for Q1 2026.
- Quarterly Total Liabilities rose 6.37% year-over-year to $106.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.9 million (up 6.37% YoY) and the FY2025 annual result came in at $103.2 million, down 0.91% from the prior year.
- Total Liabilities was $106.9 million for Q1 2026 at Treace Medical Concepts, up from $103.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $116.3 million in Q1 2024 and bottomed at $59.7 million in Q1 2022.
- A 5-year average of $101.0 million and a median of $103.2 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 134.33% — and 2025, when it declined 13.61%.
- Treace Medical Concepts' Total Liabilities stood at $98.5 million in 2022, then grew by 15.71% to $114.0 million in 2023, then dropped by 8.57% to $104.2 million in 2024, then declined by 0.91% to $103.2 million in 2025, then rose by 3.55% to $106.9 million in 2026.
- Business Quant data shows TMCI's Total Liabilities at $106.9 million in Q1 2026, $103.2 million in Q4 2025, and $107.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.68 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 18.55 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.17 Bn |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | 106.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.91 Mn |
| Dec 31, 2025 | 103.25 Mn |
| Sep 30, 2025 | 107.40 Mn |
| Jun 30, 2025 | 108.83 Mn |
| Mar 31, 2025 | 100.51 Mn |
| Dec 31, 2024 | 104.20 Mn |
| Sep 30, 2024 | 108.02 Mn |
| Jun 30, 2024 | 113.94 Mn |
| Mar 31, 2024 | 116.34 Mn |
| Dec 31, 2023 | 113.97 Mn |
| Sep 30, 2023 | 102.50 Mn |
| Jun 30, 2023 | 99.68 Mn |
| Mar 31, 2023 | 91.55 Mn |
| Dec 31, 2022 | 98.50 Mn |
| Sep 30, 2022 | 94.24 Mn |
| Jun 30, 2022 | 87.01 Mn |
| Mar 31, 2022 | 59.69 Mn |
| Dec 31, 2021 | 47.75 Mn |
| Sep 30, 2021 | 40.22 Mn |
| Jun 30, 2021 | 39.39 Mn |